# Glaxosmithkline Capital (Glaxosmithkline Capital PLC)

Public limited company registered in London, classed under “Financial intermediation not elsewhere classified”.

- Company number: 02258699
- Status: Active
- Type: Public limited company
- Incorporated: 16 May 1988
- Registered office: 79 New Oxford Street, London, WC1A 1DG
- Location: London
- Activity: Financial intermediation not elsewhere classified

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Glaxosmithkline Capital do?

Public limited company registered in London, classed under “Financial intermediation not elsewhere classified”.

### How much turnover does Glaxosmithkline Capital make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/glaxosmithkline-capital-02258699

### Is Glaxosmithkline Capital profitable?

Glaxosmithkline Capital's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Glaxosmithkline Capital?

Its directors are Victoria Anne Whyte, Julie Belita Brown, Timothy John Woodthorpe, Edinburgh Pharmaceutical Industries Limited, Glaxo Group Limited. Its owners are shown to subscribers.

### Where is Glaxosmithkline Capital based?

Its registered office is 79 New Oxford Street, London, WC1A 1DG, in London.

### When was Glaxosmithkline Capital founded?

Glaxosmithkline Capital PLC was incorporated on 16 May 1988.

### Is Glaxosmithkline Capital still trading?

The register lists Glaxosmithkline Capital PLC as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-05-22: Full accounts made up to 31 December 2025
- 2026-03-03: Appointment of Mr Timothy John Woodthorpe as a director on 2 March 2026
- 2026-02-15: Statement of company's objects
- 2026-01-28: Memorandum and Articles of Association
- 2026-01-28: Resolutions
- 2025-05-23: Full accounts made up to 31 December 2024
- 2024-09-23: Register(s) moved to registered office address 79 New Oxford Street London WC1A 1DG
- 2024-09-23: Register(s) moved to registered inspection location
- 2024-09-23: Director's details changed for Mrs Julie Belita Brown on 11 September 2024
- 2024-09-23: Secretary's details changed for Mrs Victoria Anne Whyte on 11 September 2024
- 2024-09-11: Registered office address changed from 980 Great West Road, Brentford, Middlesex, TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024
- 2024-07-18: Register inspection address has been changed
- 2024-05-21: Full accounts made up to 31 December 2023
- 2023-08-16: Director's details changed for Glaxo Group Limited on 6 June 2023
- 2023-05-11: Appointment of Mrs Julie Belita Brown as a director on 1 May 2023
- 2023-05-11: Termination of appointment of Iain James Mackay as a director on 1 May 2023
- 2023-05-05: Full accounts made up to 31 December 2022
- 2022-05-17: Full accounts made up to 31 December 2021
- 2021-05-07: Full accounts made up to 31 December 2020
- 2020-09-07: Full accounts made up to 31 December 2019
- 2019-05-10: Appointment of Mr Iain James Mackay as a director on 1 May 2019
- 2019-05-07: Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019
- 2019-05-01: Full accounts made up to 31 December 2018
- 2018-06-27: Auditor's resignation (and 1 more like it since 26 February 2003)
- 2018-04-19: Full accounts made up to 31 December 2017

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/glaxosmithkline-capital-02258699